CWM
MRK icon

Centric Wealth Management’s Merck MRK Stock Holding History

Centric Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
3,525
-716
-17% -$82.7K 0.08% 142
2025
Q4 		$481K Sell
4,241
-161
-4% -$15.1K 0.1% 130
2025
Q3 		$378K Sell
4,402
-25,194
-85% -$2.08M 0.08% 136
2025
Q2 		$2.39M Buy
29,596
+1,519
+5% +$121K 0.57% 63
2025
Q1 		$2.52M Buy
28,077
+4,075
+17% +$380K 0.66% 53
2024
Q4 		$2.39M Buy
24,002
+174
+0.7% +$17.9K 0.65% 47
2024
Q3 		$2.4M Buy
23,828
+379
+2% +$45K 0.64% 55
2024
Q2 		$2.94M Buy
23,449
+894
+4% +$115K 0.85% 37
2024
Q1 		$2.91M Buy
22,555
+1,246
+6% +$154K 0.93% 32
2023
Q4 		$2.69M Buy
21,309
+1,313
+7% +$136K 0.89% 29
2023
Q3 		$2.06M Buy
19,996
+844
+4% +$91K 0.86% 30
2023
Q2 		$2.11M Buy
19,152
+531
+3% +$60.3K 0.84% 30
2023
Q1 		$1.98M Sell
18,621
-591
-3% -$63.8K 0.86% 30
2022
Q4 		$2.13M Sell
19,212
-522
-3% -$53.4K 1.08% 24
2022
Q3 		$1.7M Buy
19,734
+290
+1% +$25.9K 0.68% 37
2022
Q2 		$1.77M Buy
19,444
+471
+2% +$41.8K 0.65% 39
2022
Q1 		$1.56M Buy
18,973
+703
+4% +$55.4K 0.49% 52
2021
Q4 		$1.4M Buy
18,270
+1,389
+8% +$111K 0.46% 62
2021
Q3 		$1.27M Buy
16,881
+314
+2% +$23.9K 0.47% 56
2021
Q2 		$1.29M Sell
16,567
-12,929
-44% -$962K 0.45% 58
2021
Q1 		$2.17M Buy
29,496
+1,402
+5% +$103K 0.62% 44
2020
Q4 		$2.19M Buy
28,094
+17,755
+172% +$1.36M 0.68% 35
2020
Q3 		$805K Sell
10,339
-2,831
-21% -$222K 0.61% 43
2020
Q2 		$972K Buy
13,170
+2,831
+27% +$213K 0.51% 53
2020
Q1 		$805K Sell
10,339
-349
-3% -$27.4K 0.61% 43
2019
Q4 		$927K Buy
10,688
+349
+3% +$28.7K 0.74% 38
2019
Q3 		$805K Buy
10,339
+640
+7% +$51.3K 0.61% 43
2019
Q2 		$776K Buy
9,699
+138
+1% +$10.6K 0.68% 41
2019
Q1 		$759K Sell
9,561
-5,936
-38% -$444K 0.7% 39
2018
Q4 		$1.13M Buy
+15,497
New +$1.09M 0.99% 18

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Centric Wealth Management's MRK Position: Q1 2026 in Review

Centric Wealth Management reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $82.7K and leaving 3,525 shares worth $399K. The position accounts for 0.08% of the portfolio, ranked #142.

Centric Wealth Management first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.94M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Centric Wealth Management held 3,525 shares of Merck worth $399K as of Q1 2026.
  • Centric Wealth Management sold 716 Merck shares in Q1 2026, an estimated $82.7K.
  • Merck made up 0.08% of Centric Wealth Management's portfolio in Q1 2026, its #142 holding.
  • Centric Wealth Management first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Centric Wealth Management's Merck position peaked at $2.94M in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Centric Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.